PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer.

August 4, 2026| Source: Proceedings of the National Academy of Sciences of the United States of America

Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to meet their increased biosynthetic and energetic demands. Although cells possess the capacity for de novo serine biosynthesis, most transformed cancer cells preferentially rely on exogenous serine uptake to sustain their growth, yet the regulatory mechanisms driving this metabolic dependency remain poorly understood. Here, we uncover a mechanism by which Polo-like kinase 1 (PLK1), frequently overexpressed in prostate cancer, orchestrates a metabolic shift in serine and sphingolipid metabolism through phosphorylation of phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme of the serine synthesis pathway (SSP). Specifically, PLK1 directly phosphorylates PHGDH at S512, S513, and S517, leading to a marked reduction in its protein level and enzymatic activity. This downregulation of de novo serine biosynthesis forces cancer cells to increase their reliance on exogenous serine uptake via the ASCT2 transporter, which in turn fuels the biosynthesis of lipids, including sphingolipids essential for tumor growth and survival. Our findings suggest that targeting the SSP, serine uptake, or downstream lipid biosynthesis pathways may represent promising therapeutic strategies in advanced cancers characterized by PLK1 dysregulation.

Read the original source →

Plant fiber exploitation contributed to the emergence of ground-edged cutting tools in North China.

Ground-edged cutting tools are widely regarded as technological hallmarks of early agriculture in North China, commonly hypothesized to have been developed primarily for cereal harvesting. Yet the functional foundations of this innovation remain insufficiently tested. This study integrates use-wear and microfossil analyses of 140 stone tools from the Peiligang site, with experimental data, to reassess their roles within long-term trajectories of technological change from the Late Paleolithic to

Artificial IntelligenceSeptember 28, 2026

Neural network-augmented Pfaffian wave-functions for scalable simulations of interacting fermions.

Developing accurate numerical methods for strongly interacting fermions is crucial for improving our understanding of various quantum many-body phenomena, especially unconventional superconductivity. Recently, neural quantum states have emerged as a promising approach for studying correlated fermions, highlighted by the hidden fermion and backflow methods, which use neural networks to model corrections to fermionic quasiparticle orbitals. In this work, we expand these ideas to the space of Pfaff

Artificial IntelligenceSeptember 26, 2026

Why friends in common reveal network stars.

The Friendship Paradox states that, on average, your friends have more friends than you do. We extend this to common friends-those who appear in multiple people's friend lists. We show that the more people who share a common friend, the more connected that person tends to be, and we derive an expression quantifying this progression. In a regional Facebook network, a common friend to three randomly sampled individuals has on average more friends than 99.9% of the network. In a citation network, a

Artificial IntelligenceSeptember 26, 2026

Sensory context improves language prediction in humans and LLMs.

Language is a fundamental human capacity. Large language models (LLMs) have presented the first viable model of language outside of humans, yet how these models learn and use language differs significantly from humans. Here, we compare LLMs and humans predicting language with varying levels of sensory information-from disembodied written text to audiovisual videos of speakers-to demonstrate that, in both humans and LLMs, sensory context is critical for optimal performance. We asked human partici

Artificial IntelligenceSeptember 10, 2026

Treatment Decisions in Multiple Myeloma.

Revolutions in transplantation and targeted and immune therapies have transformed multiple myeloma from a disease with an associated survival of a few years into one for which functional cure is an emerging goal. This abundance of effective therapies has created clinical complexity. Here we provide a practical framework, anchored in trial evidence and informed by emerging biologic discoveries, for the navigation of treatment decisions across the disease spectrum. We outline how cytogenetic and g